Shiemke Andrew K, Arp Daniel J, Sayavedra-Soto Luis A
Department of Biochemistry and Molecular Pharmacology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, West Virginia 26506-9142, USA.
J Bacteriol. 2004 Feb;186(4):928-37. doi: 10.1128/JB.186.4.928-937.2004.
Diphenyliodonium (DPI) is known to irreversibly inactivate flavoproteins. We have found that DPI inhibits both membrane-bound methane monooxygenase (pMMO) from Methylococcus capsulatus and ammonia monooxygenase (AMO) of Nitrosomonas europaea. The effect of DPI on NADH-dependent pMMO activity in vitro is ascribed to inactivation of NDH-2, a flavoprotein which we proposed catalyzes reduction of the quinone pool by NADH. DPI is a potent inhibitor of type 2 NADH:quinone oxidoreductase (NDH-2), with 50% inhibition occurring at approximately 5 micro M. Inhibition of NDH-2 is irreversible and requires NADH. Inhibition of NADH-dependent pMMO activity by DPI in vitro is concomitant with inhibition of NDH-2, consistent with our proposal that NDH-2 mediates reduction of pMMO. Unexpectedly, DPI also inhibits pMMO activity driven by exogenous hydroquinols, but with approximately 100 micro M DPI required to achieve 50% inhibition. Similar concentrations of DPI are required to inhibit formate-, formaldehyde-, and hydroquinol-driven pMMO activities in whole cells. The pMMO activity in DPI-treated cells greatly exceeds the activity of NDH-2 or pMMO in membranes isolated from those cells, suggesting that electron transfer from formate to pMMO in vivo can occur independent of NADH and NDH-2. AMO activity, which is known to be independent of NADH, is affected by DPI in a manner analogous to pMMO in vivo: approximately 100 micro M is required for 50% inhibition regardless of the nature of the reducing agent. DPI does not affect hydroxylamine oxidoreductase activity and does not require AMO turnover to exert its inhibitory effect. Implications of these data for the electron transfer pathway from the quinone pool to pMMO and AMO are discussed.
已知二苯基碘化鎓(DPI)可不可逆地使黄素蛋白失活。我们发现DPI既能抑制来自荚膜甲基球菌的膜结合型甲烷单加氧酶(pMMO),也能抑制欧洲亚硝化单胞菌的氨单加氧酶(AMO)。DPI对体外依赖NADH的pMMO活性的影响归因于NDH - 2的失活,NDH - 2是一种黄素蛋白,我们认为它催化NADH对醌池的还原。DPI是2型NADH:醌氧化还原酶(NDH - 2)的强效抑制剂,在约5微摩尔时出现50%的抑制率。对NDH - 2的抑制是不可逆的,且需要NADH。DPI在体外对依赖NADH的pMMO活性的抑制与对NDH - 2的抑制同时发生,这与我们提出的NDH - 2介导pMMO还原的观点一致。出乎意料的是,DPI还能抑制由外源对苯二酚驱动的pMMO活性,但达到50%抑制率大约需要100微摩尔DPI。在全细胞中,抑制甲酸、甲醛和对苯二酚驱动的pMMO活性也需要类似浓度的DPI。经DPI处理的细胞中的pMMO活性大大超过从这些细胞中分离出的膜中NDH - 2或pMMO的活性,这表明在体内从甲酸到pMMO的电子传递可以独立于NADH和NDH - 2发生。已知与NADH无关的AMO活性,在体内受DPI影响的方式与pMMO类似:无论还原剂的性质如何,达到50%抑制率大约需要100微摩尔。DPI不影响羟胺氧化还原酶活性且不需要AMO周转来发挥其抑制作用。讨论了这些数据对从醌池到pMMO和AMO的电子传递途径的意义。